India’s 1st miRNA Based Breast Cancer Test
Simple Steps To Early Detection
Prerna.
Inspired innovation.
Prerna.
Inspired innovation.
Prerna is leading a molecular shift in medicine using microRNAs (miRNAs), nature’s own gene regulators, to transform how we detect and treat disease.
From Cantel, the world’s first miRNA-based liquid biopsy for breast cancer to a growing pipeline of RNA-targeted therapies, Prerna is reimagining healthcare to be earlier, more accurate, and deeply personal.
Built on world-class science and global IP, and backed by leading oncologists, Prerna is advancing precision medicine that’s accessible, affordable, and ready for the real world.
From Cantel, the world’s first miRNA-based liquid biopsy for breast cancer to a growing pipeline of RNA-targeted therapies, Prerna is reimagining healthcare to be earlier, more accurate, and deeply personal.
Built on world-class science and global IP, and backed by leading oncologists, Prerna is advancing precision medicine that’s accessible, affordable, and ready for the real world.